| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |